|
Today, we are releasing a new report on SunSi Energies, Inc. (OTCQB – SSIE - $5.09.) But, don’t be fooled! This is far different from any other report you have seen on SSIE. Our previous reports on SSIE have been under our sponsored research offering known as Opportunity Research. However, due to major changes in the business model and the pending move upstream to NASDAQ, we are now covering SSIE via our non-sponsored format, Select Research.
SSIE is only the 3rd company we have covered in this format and the other 2 had monster gains following our coverage release. We expect the same can happen with SSIE in 2013, as we have a $9.00 price target.
|
|
Read more...
|
|
Today we are initiating coverage of North American Oil and Gas Corp, a pure-play ground floor opportunity in the oil and gas exploration and production space. With funding in place from a key partner and properties in close proximity to the largest oil and gas find in California, the Company is in a great position to generate solid returns. Drilling has begun on one prospect and we expect a series of catalysts in the near term.
|
|
Read more...
|
|
The crown jewel in the Itonis family is Itonis Pharmaceuticals, which is developing what may be the first over-the-counter, systemically active preparation delivered via a nasal and/or sublingual spray for the alleviation of mild to moderate nausea. Itonis Pharmaceuticals is led by the famed homeopathic and nutraceutical pioneer and a founder of the Firm that launched the popular Zicam® Cold Remedy. Under his guidance, sales quickly reached the $100M mark, prior to his departure in the late 1990’s.
|
|
Read more...
|
|
Today, we are initiating coverage of Yellow7 (OTCQB:YLLC). The bottom line is that this emerging media company with diversified properties and divisions has a current valuation that reflects only one division alone, thereby providing investors with the other divisions for “free”. At current levels, the stock is only trading roughly 1.5x twelve months trailing reported revenue and should substantially increase total sales in the coming quarters.
|
|
Read more...
|
|
Today, we are initiating coverage of Fairmont Resources (FMR.V, OTCPK:FRSSF). The bottom line is that this is an expensive way to play the likely success of one of North America’s largest gold exploration projects.
|
|
Read more...
|
|
Today, we are initiating coverage of Intertainment Media (INT.V, OTCQX:ITMTF). This is an amazing asset play that will be unlocking value very soon with one of its divisions expected to go public at a valuation of $200-$400M in early 2013.
|
|
Read more...
|
Today, is a cool day for 2 reasons. First, today’s date is 10/11/12. Nice and consecutive.
Plus, we are issuing an update on Nuvilex (OTCQB – NVLX)for the first time in a while. The Company released results of a second Phase 2 trial for pancreatic cancer that we believe are even better than the first one.
I know investors are ambivalent or downright dismissive of news and so the stock has gone nowhere recently. However, I defy anyone to read through results and compare the progress to the current market cap, and tell me the stock is not incredibly cheap.
Savvy investors and traders will pounce while the rest of the Street ignores NVLX and they could be well rewarded as more milestone events occur.
|
|
Read more...
|
|
Today, we are initiating coverage of Lorus Therapeutics, Inc. (LOR.TO, OTCQB - LRUSF) a biopharma that is focused on novel anticancer drugs. The Company may be the most undervalued sleeper in the entire biotech segment. LOR has multiple anti-cancer therapies on 2 separate platforms, with several cancer indications, representing billions of dollars in market potential. The patent portfolio is vast, with 29 patents awarded and 19 pending.
|
|
Read more...
|
|
Good afternoon! Today we are initiating coverage of Terra Tech Corp. (OTCBB – TRTC) a company that is changing the way produce is grown and distributed. Terra Tech has quietly emerged as one of the country’s most important agriculture companies. Management is revolutionizing and helping drive the growth of indoor agriculture cultivation through its proprietary cultivation and production systems, while enhancing distribution of locally-owned produce from specialty stores to mass market retail chains.
Terra Tech just announced a landmark partnership that will serve as a model for future transactions and it could result in millions in annual revenue and a 51% ownership for Terra Tech.
Management has engaged a vertical integration strategy via M&A and strategic partnerships that could ultimately drive TRTC stock to the $2.00 level. This strategy should propel revenue from $3M in 2012 to roughly $30M in 2 years. With a huge top-line growth rate and a nearly 20% operating margin, we rate TRTC Speculative Buy.
|
|
Read more...
|
|
Today we are initiating coverage of Creative Edge Nutrition (OTCPK – FITX) a leading nutritional supplement company focused on the active lifestyle consumer segment. The Company is profitable and just acquired one of the most popular brands in the business that generates $10M annually in sales. Due to the vertical integration and roll-up strategy, we believe FITX could generate $60M in FY13. Our target is $0.35
|
|
Read more...
|
|
|
<< Start < Prev 41 42 43 44 45 46 47 Next > End >>
|
|
Page 43 of 47 |
